Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 385 - 392 of 12092 results
Health Law Diagnosed – New Year's Gratitude
February 3, 2025| Podcast| Viewpoint
EnforceMintz — Health Care False Claims Act Statistical Year in Review
February 3, 2025| Blog| Viewpoint
M&A Buyers Beware: Who Bears the Cost of Defense of a Third-Party Claim?
February 1, 2025| News
Telephone and Texting Compliance News — January 2025
January 31, 2025| Article| Viewpoint
Telephone and Texting Compliance News: Regulatory Update — Robocalling Proceedings Potentially Impacted by Regulatory Freeze
January 31, 2025| Article| Viewpoint
Telephone and Texting Compliance News: Litigation Update — Eleventh Circuit Knocks Out One-to-One Consent
January 31, 2025| Article| Viewpoint
DeepSeek’s Rise Creates Urgency and Uncertainty for President Trump’s AI Agenda — AI: The Washington Report
January 30, 2025| Article| Viewpoint
Avoiding the Provisional Application Filing Pitfall of Narrowed Claim Interpretation
January 29, 2025| Article| Viewpoint
News & Press Releases
Mintz advised the creators of Morbid, one of the top-charting true crime podcasts, in a multi-year agreement to move to SiriusXM from Wondery. The deal gives SiriusXM exclusive advertising rights for the audio and video formats of the podcast.
Mintz Advises CVC DIF in Acquisition of SBA Communications’ Canadian Tower Infrastructure Platform
August 06, 2025
Mintz advised CVC DIF, the dedicated infrastructure investment strategy of global private markets manager CVC, in its agreement to acquire SBA Communications’ Canadian wireless tower business, one of Canada’s leading independent owners and operators of wireless communications towers. The transaction is expected to close in the fourth quarter of 2025, subject to customary closing conditions.
Mintz advised the underwriters in connection with a $69 million public offering by Larimar Therapeutics, Inc. of 21,562,500 shares of its common stock at a price to the public of $3.20 per share. The gross proceeds to Larimar from the offering were $69 million before deducting underwriting discounts and commissions and other offering expenses.
Events
Podcasts
Mintz On Air: Practical Policies — A Private Equity Non-Compete Primer
July 15, 2025| Podcast|
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|